W. Labaki (Ann Arbor, United States of America), A. Ben Saad (Monastir, Tunisia), S. Skoczynski (Katowice, Poland)
Comparison of CAT and mMRC in terms of assessing symptom status in stable COPD patients
E. Ertan Yazar (Istanbul, Turkey), E. Niksarlioglu (Istanbul, Turkey), B. Yigitbas (Istanbul, Turkey), T. Mandal (Istanbul, Turkey)
|  |
COPD Assessment test (CAT) Score as a predictor of severe exacerbations in veterans
A. Guerrero Cignarella (Miami, United States of America), P. Baghaei Shiva (Miami, United States of America), K. Tovar (Miami, United States of America), G. Urdaneta (Miami, United States of America), I. Vital (Miami, United States of America), G. Holt (Miami, United States of America), M. Mirsaeidi (Miami, United States of America), R. Calderon-Candelario (Miami, United States of America), M. Campos (Miami, United States of America)
| |
The Capacity of Daily Living during the Morning (CDLM) questionnaire: Evaluating the impact of morning symptoms in COPD
A. Nuñez (Barcelona, Spain), M. Barrecheguren (Barcelona, Spain), M. Calle (Madrid, Spain), R. Casamor (Barcelona, Spain), M. Miravitlles (Barcelona, Spain), C. Esquinas (Barcelona, Spain)
| |
Effect of treatment on morning symptoms in COPD. Correlation between doctors and patients in the evaluation of symptoms. SINCON Study
A. Baloira Villar (Pontevedra, Spain), J. Trigueros (Toledo, Spain), J. Rodriguez Gozález-Moro (Alcalá de Henares, Spain), E. Sanjuan (Viladecans, Spain), R. Casamor (Barcelona, Spain)
| |
Qualitative research evaluating patient preferences for a new COPD treatment
M. Schroeder (Brentford, United Kingdom), L. Eliasson (London, United Kingdom), K. Hall (London, United Kingdom), J. Macey (Abingdon, United Kingdom), S. Bracey (Abingdon, United Kingdom), P. Jones (Collegeville, United States of America), A. Ismaila (Collegeville, United States of America)
|  |
Differences in medication adherence in chronic cbstructive pulmonary disease associated with beliefs on medications
H. Arikan (Istanbul, Turkey), D. Duman (Istanbul, Turkey), Z. Uslu (Istanbul, Turkey), D. Kocakaya (Istanbul, Turkey), E. Eryuksel (Istanbul, Turkey)
| |
Abstract presentation PA4010
| |
Relationships among depression, pain, patient activation, and fatigue in patients with COPD
J. Lee (Kingston, United States of America), H. Nguyen (Pasadena, United States of America), V. Fan (Seattle, United States of America)
| |
Chronic pain in patients with chronic obstructive pulmonary disease
F. Walid (Sfax, Tunisia), C. Malek (Sfax, Tunisia), K. Wajdi (Sfax, Tunisia), M. Nadia (Sfax, Tunisia), B. Najla (Sfax, Tunisia), M. Sameh (Sfax, Tunisia), K. Amina (Sfax, Tunisia), A. Hajer (Sfax, Tunisia), R. Karim (Sfax, Tunisia), Y. Ilhem (Sfax, Tunisia), K. Samy (Sfax, Tunisia)
| |
Assessing activity-related cognitions in chronic obstructive pulmonary disease (COPD): validation of the activity cognitions instrument (ACI)
M. Looijmans (Nijmegen, Netherlands), I. Van Nunen (Nijmegen, Netherlands), M. Klaassen (Nijmegen, Netherlands), J. Peters (Nijmegen, Netherlands), J. Vercoulen (Nijmegen, Netherlands)
| |
French translation and validation of the C- and D-PPAC PROactive questionnaires to measure physical activity in patients with chronic obstructive pulmonary disease.
T. Vaidya (Poitiers, France), V. Thomas-Ollivier (Nantes, France), F. Hug (Nantes, France), A. Bernady (Cambo-les-Bains, France), F. Costes (Clermont Ferrand, France), H. Ouksel (Beaucouzé, France), C. De Bisschop (Poitiers, France), A. Chambellan (Nantes, France)
| |
Patient And Carer Perceptions Regarding The Advanced Lung Disease Service – A New Model Of Integrated Respiratory And Palliative Care
T. Moran (Melbourne, Australia), M. Thompson (Melbourne, Australia), B. Le (Melbourne, Australia), L. Irving (Melbourne, Australia), N. Smallwood (Melbourne, Australia)
| |
Evaluation of COPD Patient’s Relatives Assessment of Disease Awarness, Load of Care Giving and Loss of Workforce: Turkish Thoracic Society COPD Working Group.
A. Baha (Ankara, Turkey), N. Kokturk (Ankara, Turkey), E. Yildirim (Istanbul, Turkey), I. Ozmen (Istanbul, Turkey), A. Gurgun (Izmir, Turkey), F. Topcu (Diyarbakir, Turkey), E. Akpinar (Ankara, Turkey), F. Elmas (Izmir, Turkey), H. Sen (Diyarbakir, Turkey), N. Ogan (Ankara, Turkey), Y. Onder (Sivas, Turkey), T. Dogan (Sivas, Turkey), M. Polatli (Aydin, Turkey), Z. Bingol (Istanbul, Turkey), T. Ece (Istanbul, Turkey), E. Akguney (Erzurum, Turkey), M. Akgun (Erzurum, Turkey), E. Ozgur (Mersin, Turkey), S. Nayci (Mersin, Turkey), I. Serifoglu (Ankara, Turkey), C. Ates (Van, Turkey)
| |
The impact of low forced vital capacity on comorbidities and behavior restriction in chronic obstructive pulmonary disease
N. Kang (Seoul, Republic of Korea), S. Shin (Seoul, Republic of Korea), S. Gu (Seoul, Republic of Korea), S. Lim (Seoul, Republic of Korea), J. Cho (Seoul, Republic of Korea), H. Gil (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea), H. Lee (Seoul, Republic of Korea)
| |
Differences in psychological stage and functional capacity between caregivers of patients with COPD and heart failure in accordance with their levels of perceived self-efficacy
M. Rivera-Rodriguez (Mexico, Mexico), V. Pelaez-Hernandez (Mexico, Mexico), A. Orea-Tejeda (Mexico, Mexico), A. Figueroa-Herrera (Mexico, Mexico), D. Gonzalez-Islas (Mexico, Mexico), C. Olivo-Villalobos (Mexico, Mexico), C. Chavez-Mendez (Mexico, Mexico), G. Davila-Said (Mexico, Mexico), S. Torres-Montiel (Mexico, Mexico), L. Castillo-Aguilar (Mexico, Mexico), K. Balderas-Muñoz (Mexico, Mexico), L. Aguilera-Carrillo (Mexico, Mexico), R. Sanchez-Santillan (Mexico, Mexico), E. Perez-Cabañas (Mexico, Mexico)
| |
Drivers of respiratory symptoms in COPD patients
K. Johnson (Vancouver, Canada), A. Safari (Vancouver, Canada), W. Tan (Vancouver, Canada), J. Bourbeau (Montreal, Canada), M. Sadatsafavi (Vancouver, Canada)
| |
PAIN AND FRAILTY IN COPD PATIENTS: RELATIONSHIP AND IMPACT ON WELLBEING AND HEALTH STATUS
S. Antoniu (Iasi, Romania), A. Apostol (Iasi, Romania), R. Gobbens (Amsterdam, Netherlands)
| |
Physicians’ perceptions on gender differences in the diagnosis and management of COPD
C. Raherison-Semjen (Bordeaux, France), K. Mezzi (Basel, Switzerland), K. Kostikas (Basel, Switzerland), A. Mackay (London, United Kingdom), D. Singh (Manchester, United Kingdom)
| |
Impact of a educational program in the use of inhalers in patients derived to a respiratory rehabilitation unit
P. Mariscal Aguilar (Madrid, Spain), J. Tenes Mayen (Madrid, Spain), T. Torralba (Madrid, Spain), R. Álvarez Sala-Walther (Madrid, Spain), M. Marin (Madrid, Spain), C. Carpio (Madrid, Spain), E. Zamarron De Lucas (Madrid, Spain)
| |